|
End-of-day quote
Shanghai S.E.
2026-09-28
|
5-day change | 1st Jan Change | ||
| 128.08 CNY | +2.26% |
|
+29.33% | +219.80% |
| Market Cap | 8.9B 1.33B 1.17B 1.1B 1B 1.88B 127B 1.89B 13.21B 5.1B 65.06B 4.98B 4.87B 209B | P/E 2024 |
-42.6x | P/E 2025 | -36.1x |
|---|---|---|---|---|---|
| Enterprise Value | 7.25B 1.08B 950M 899M 815M 1.53B 104B 1.54B 10.75B 4.15B 52.97B 4.06B 3.97B 170B | EV / Sales 2024 |
4.57x | EV / Sales 2025 | 7.78x |
| Free-Float |
30.99% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +2.26% | ||
| 1 week | +29.33% | ||
| Current month | +86.24% | ||
| 1 month | +54.97% | ||
| 3 months | +280.40% | ||
| 6 months | +219.80% | ||
| Current year | +219.80% |
| 1 week | 115.8 | 135.61 | |
| 1 month | 59 | 135.61 | |
| Current year | 33.2 | 135.61 | |
| 1 year | 33.2 | 135.61 | |
| 3 years | 28.56 | 135.61 | |
| 5 years | 28.56 | 135.61 | |
| 10 years | 28.56 | 135.61 |
| Manager | Title | Age | Since |
|---|---|---|---|
Hua Xing Zhu
CEO | Chief Executive Officer | 54 | 2009-09-06 |
Dong Ye Zhang
DFI | Director of Finance/CFO | 53 | 2013-06-30 |
Li Lan Cui
CTO | Chief Tech/Sci/R&D Officer | 36 | 2015-06-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Hua Xing Zhu
CHM | Chairman | 54 | 2009-09-06 |
Yu Jian Zhao
BRD | Director/Board Member | 54 | 2019-01-31 |
Du Qiang Wang
BRD | Director/Board Member | 41 | 2021-04-14 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.26% | +29.33% | +199.32% | +149.91% | 1.3B | ||
| -0.80% | +28.07% | +705.55% | +98.39% | 79.4B | ||
| -4.54% | -4.15% | +33.40% | -9.65% | 78.69B | ||
| +2.80% | +3.60% | -6.34% | -27.82% | 59.52B | ||
| -0.89% | +2.11% | +7.92% | +170.43% | 46.58B | ||
| +2.49% | +0.14% | -8.95% | +33.71% | 46.53B | ||
| +0.48% | +6.12% | +66.48% | -11.20% | 33.63B | ||
| +0.75% | -0.39% | +50.93% | +111.17% | 25.11B | ||
| -3.56% | -0.47% | +3.11% | +135.37% | 22.13B | ||
| +0.73% | -1.70% | +61.19% | +100.64% | 15.31B | ||
| Average | +0.06% | +4.65% | +111.26% | +75.09% | 40.82B | |
| Weighted average by Cap. | -0.35% | +6.72% | +154.35% | +54.02% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 128M 19.01M 16.72M 15.82M 14.34M 26.95M 1.82B 27.09M 189M 73.02M 932M 71.36M 69.82M 2.99B | 146M 21.82M 19.2M 18.16M 16.47M 30.93M 2.09B 31.1M 217M 83.83M 1.07B 81.93M 80.16M 3.44B |
| Net income | -54.42M -8.11M -7.13M -6.75M -6.12M -11.5M -778M -11.56M -80.71M -31.15M -398M -30.44M -29.79M -1.28B | -77.78M -11.59M -10.2M -9.64M -8.75M -16.43M -1.11B -16.52M -115M -44.52M -568M -43.52M -42.58M -1.82B |
| Net Debt | -1.73B -259M -227M -215M -195M -366M -24.81B -368M -2.57B -993M -12.68B -971M -950M -40.7B | -1.65B -247M -217M -205M -186M -349M -23.66B -351M -2.45B -947M -12.09B -926M -906M -38.81B |
Employees
696
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-28 | CN¥128.08 | +2.26% | 8,487,401 |
| 26-09-24 | CN¥125.25 | +1.96% | 8,042,989 |
| 26-09-23 | CN¥122.84 | -1.33% | 8,950,843 |
| 26-09-22 | CN¥124.50 | +4.76% | 12,290,599 |
- Stock Market
- Stocks
- 688137 Stock
Select your edition
All financial news and data tailored to specific country editions
















